CD40LG and B-cell chronic lymphocytic leukemia: Reduced levels of IgM and IgG are observed in patients with SLL although the IgA concentration is well preserved [40], a factor that has been recently correlated with reduced infection risk in patients with B-CLL who have been treated with ibrutinib [41].